Geoffrey Paul Kempler

Biography

Mr Kempler has served as Chairman of our Board of Directors since November 1997 of PRANA Biotechnology and between November 1997 and August 2004 he served as our Chief Executive Officer, and in June 2005 he again assumed the position of Chief Executive Officer.  He is one of the founders of our company. He is a qualified psychologist. he, who has extensive experience in investment and business development, has managed our operations to date and has been responsible for the implementation of our strategic plan and the commercialization of our technology.  He holds a B.Sc degree in science from Monash University and Grad. Dip. App. Soc. Psych. degree from Swinburne University. He was appointed as a Non-Executive Chairman of Opthea Limited, an ASX listed drug development company developing innovative, biologics-based therapies for the treatment of eye diseases, on November 30, 2015.

Research Interest

Alzheimer’s and Huntington's diseases, Parkinson’s disease and other movement disorders (PBT434) and brain cancer (PBT519), pre-clinical toxicology testing, Metal Protein Attenuating Compounds, neurodegenerative diseases.